FindTrial
Sign In

Single centre study comparing results of pathologic analysis of EUS-FNA with EUS-TCB in patients with enlarged mediastinal lymph nodes and evaluating mutation analysis on EUS-TCB in patients with NSCLC.

Single centre study comparing results of pathologic analysis of EUS-FNA with EUS-TCB in patients with enlarged mediastinal lymph nodes and evaluating mutation analysis on EUS-TCB in patients with NSCLC. - Assessment of EUS-FNA compared to EUS-FNA and EUS-TCB.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35924
Enrollment
102
Registered
2011-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

enlarged lymfnodes and malignancy

Interventions

None listed

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with large mediastinal lymph nodes (>2cm) at location N7, N4L on CT or PET-CT. 2. Age of 18-85 years. 3. ASA classification 1 - 3

Exclusion criteria

Exclusion criteria: 1. ASA classification > 3 (see appendix A) 2. Obstructing oral or laryngeal disease. 3. Severe maxillofacial deformity.

Design outcomes

Primary

MeasureTime frame
Pathologic diagnosis; mutation analysis in NSCLC—

Secondary

MeasureTime frame
Complications—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)